Dow Down 0.25% Nasdaq Down 0.14%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
0.74 Up 0.07(9.57%) Sep 29, 4:00PM EDT
|After Hours : 0.74 Down 0.00 (0.01%) Sep 29, 4:53PM EDT
Prev Close:0.68
Open:0.67
Bid:0.74 x 500
Ask:0.86 x 10000
1y Target Est:5.13
Beta:2.25
Next Earnings Date:N/A
Day's Range:0.67 - 0.76
52wk Range:0.67 - 3.93
Volume:851,724
Avg Vol (3m):490,659
Market Cap:59.18M
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTX

Comparison

Symbol% ChgMkt Cap
CYTXUp 9.57%59.18M
ASTMUp 8.65%23.12M
BAXDown 0.55%38.94B
OSIRDown 0.39%435.04M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.42
Quarterly EPS Est (Sep-14) :-0.07
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a cell therapy company, develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback